The Nutshell

» clinical trials and genetics & genomics

Daily News Roundup

Most Recent

Scientists identify a mutation in the CRY1 gene in people with abnormal sleeping patterns.

0 Comments

23andMe customers can now receive information about genetic risk for diseases including Parkinson’s and celiac.

0 Comments

image: Mutations Linked to Secondary Cancers

Mutations Linked to Secondary Cancers

By | April 4, 2017

Childhood cancer survivors with mutations in certain cancer-risk genes have a higher risk of developing additional neoplasms later in life, according to research presented at the American Association for Cancer Research annual meeting.

0 Comments

image: DNA-Based Zika Vaccine Reaches Phase 2

DNA-Based Zika Vaccine Reaches Phase 2

By | April 4, 2017

An NIAID-sponsored clinical trial advances beyond safety testing.

0 Comments

At the annual American Association for Cancer Research meeting, researchers discuss the importance of understanding the epigenetic contributors to cancer progression and treatment response.

0 Comments

image: <em>Aedes aegypti</em> Genome Assembled From Scratch

Aedes aegypti Genome Assembled From Scratch

By | March 27, 2017

Scientists use a new technique to piece together the mosquito’s full genome.

0 Comments

image: Women Lose Vision After Stem Cell Treatment

Women Lose Vision After Stem Cell Treatment

By | March 17, 2017

The adipose-derived cells were injected into the patients’ eyes to treat age-related macular degeneration. 

1 Comment

image: House Bill Could Help Employers Dodge GINA

House Bill Could Help Employers Dodge GINA

By | March 13, 2017

HR 1313 could circumvent protections offered by the Genetic Information Nondiscrimination Act, enabling employers to incentivize employee sharing of genetic and other medical information.

2 Comments

image: Study: Most Long Noncoding RNAs Likely Functional

Study: Most Long Noncoding RNAs Likely Functional

By | March 2, 2017

Nearly 20,000 lncRNAs identified in human cells may play some role in cellular activities.

0 Comments

image: Kite’s CAR T-Cell Therapy Success

Kite’s CAR T-Cell Therapy Success

By | March 1, 2017

More than one-third of lymphoma patients in a Phase 2 trial were clear of disease at six months, and no new safety concerns arose since the company’s three-month follow up.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. A History of Screening for Natural Products to Fight Cancer
  4. March for Science: Dispatches from Washington, DC
AAAS